Pharmaceuticals, Biotechnology and Life Sciences
SEATTLE, March 09, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered…
SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation…
RENO, Nev., March 09, 2022 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing…
Brings decades of both board and management life sciences experienceBOSTON, March 09, 2022 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ:…
Company conference call and webcast at 4:30 PM ETAUSTIN, Texas, March 09, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP),…
-Near-term commercial focus on the Renewable Diesel market -Management will host a conference call today at 4:30 p.m. (ET) to…
LEXINGTON, Mass., March 09, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical…
SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the pricing of its underwritten…
Irreversible covalent menin inhibitor, BMF-219, exhibited high potency and complete growth inhibition in high-grade B-cell lymphoma and multiple myeloma (MM)…
Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ETPHILADELPHIA, March 08, 2022 (GLOBE…